Clinical Trial Update: Docusate/Senna for the Treatment of Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docusate/senna for diabetic gastroparesis was terminated, with trial results posted in October 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis

Drugs mentioned

• Docusate/Senna (docusate sodium and senna)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Diabetic Gastroparesis | Phase 2 | Status: TERMINATED | Results posted: 2020-10-23